Iovance Biotherapeutics Inc. Common Stock vs NiSource Inc Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while NiSource Inc Common Stock trades at $40.76 (market cap $19.44B). The key difference: NiSource Inc Common Stock is far larger — about 3.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and NiSource Inc Common Stock pays a 2.96% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and NiSource Inc Common Stock for 1 Days on average.
| IOVA | NI | |
|---|---|---|
Market Cap | $6.04B | $19.44B |
Volume | 14,805,993 | 3,945,959 |
Sector | Health | Utilities |
52-Week High | $14.82 | $49.08 |
52-Week Low | $1.81 | $39.00 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $36.77B |
Dividend Yield | — | 2.96% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.
Read more on NI →